MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 8, 2015, Pages 630-638

  Ma, Zhongliang ^a   Qiu, Xiang ^a   Wang, Detao ^a   Li, Yanli ^a   Zhang, Bingjie ^a   Yuan, Tianwei ^a   Wei, Jiali ^a   Zhao, Botao ^a   Zhao, Xintai ^d   Lou, Jiatao ^c   Jin, Yan ^b   Jin, Youxin ^a  

^a SHANGHAI UNIVERSITY   (China)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c SHANGHAI CHEST HOSPITAL   (China)

^d Shanghai X Pharm R/D Co Ltd   (China)

Author keywords

Migration; MiR 181a 5p; Non small cell lung cancer; Proliferation

Indexed keywords

KRAS PROTEIN, HUMAN; MICRORNA; MIRN181 MICRORNA, HUMAN; PROTEIN P21;

CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MOLECULARLY TARGETED THERAPY; NON SMALL CELL LUNG CANCER; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; MICRORNAS; MOLECULAR TARGETED THERAPY; PROTO-ONCOGENE PROTEINS P21(RAS); TRANSFECTION;

EID: 84941565930     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv054     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61: 69-90
2. Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer 2013, 52: 356-369
3. Vannini I, Fanini F, Fabbri M. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem 2013, 46: 918-925
4. Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qiu X, et al. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis. Oncol Rep 2013, 30: 492-498
5. Xing L, Su J, Guarnera MA, Zhang H, Cai L, Zhou R, Stass SA, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules. Clin Cancer Res 2015, 21: 484-489
6. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120: 15-20
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435: 834-838
8. Zhang WC, Liu J, Xu X, Wang G. The role of microRNAs in lung cancer progression. Med Oncol 2013, 30: 675
9. Frampton AE, Krell J, Jacob J, Stebbing J, Castellano L, Jiao LR. Loss of miR-126 is crucial to pancreatic cancer progression. Expert Rev Anticancer Ther 2012, 12: 881-884
10. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28: 1385-1392
11. Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 2011, 300: F602-F610
12. Liu CG, Calin GA, Volinia S, Croce CM. MicroRNA expression profiling using microarrays. Nat Protocols 2008, 3: 563-578
13. Ji DB, Chen ZG, Li M, Zhan TC, Yao YF, Zhang ZQ, Xi JZ, et al. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol Cancer 2014, 13: 86
14. Korhan P, Erdal E, Atabey N. miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Biochem Biophys Res Commun 2014, 450: 1304-1312
15. Liu M, Wang JG, Huang HZ, Hou JS, Zhang B, Wang AX. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. Biochem Biophys Res Commun 2013, 441: 364-370
16. Xiang Z, Dong X, Sun Q, Li X, Yan B. Clinical significance of up-regulated miR-181a in prognosis and progression of esophageal cancer. Acta Biochim Biophys Sin 2014, 46: 1007-1010
17. Jeon MJ, Kim EJ, Lee M, Kim H, Choi JR, Chae HD, Moon YJ, et al. MicroRNA-30d and microRNA-181a regulate HOXA11 expression in the uterosacral ligaments and are overexpressed in pelvic organ prolapse. J Cell Mol Med 2015, 19: 501-509
18. Won YS, Jeong JS, Kim SJ, Ju MH, Lee SW. Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement. Cancer Lett 2015, 356: 918-928
19. Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets. Biochim Biophys Acta 2007, 1773: 1177-1195
20. Yoon YK, Kim HP, Han SW, Oh do Y, Im SA, Bang YJ, Kim TY. KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach. Mol Carcinog 2010, 49: 353-362
21. Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH. Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Cancer Lett 2012, 319: 173-181
22. Tanic M, Yanowsky K, Rodriguez-Antona C, Andres R, Marquez-Rodas I, Osorio A, Benitez J, et al. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene. PLoS ONE 2012, 7: e38847
23. Ma ZL, Hou PP, Li YL, Wang DT, Yuan TW, Wei JL, Zhao BT, et al. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFbetaR2. Tumour Biol 2014, 36: 2481-2490
24. Sharma M, Juvvuna PK, Kukreti H, McFarlane C. Mega roles of micro-RNAs in regulation of skeletal muscle health and disease. Front Physiol 2014, 5: 239
25. Valastyan S, Weinberg RA. Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci 2011, 124: 999-1006
26. Noh H, Hong S, Dong Z, Pan ZK, Jing Q, Huang S. Impaired microRNA processing facilitates breast cancer cell invasion by upregulating urokinase-type plasminogen activator expression. Genes Cancer 2011, 2: 140-150
27. Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, Schiemann WP. TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J Clin Investigat 2013, 123: 150-163
28. Zhang X, Nie Y, Du Y, Cao J, Shen B, Li Y. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol 2012, 33: 1589-1597
29. Fei J, Li Y, Zhu X, Luo X. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS ONE 2012, 7: e32834
30. Ke G, Liang L, Yang JM, Huang X, Han D, Huang S, Zhao Y, et al. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene 2013, 32: 3019-3027
31. Shin KH, Bae SD, Hong HS, Kim RH, KangMK, Park NH. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun 2011, 404: 896-902
32. Chen G, ZhuW, Shi D, Lv L, Zhang C, Liu P, HuW. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 2010, 23: 997-1003
33. Fragoso R, Mao T, Wang S, Schaffert S, Gong X, Yue S, Luong R, et al. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet 2012, 8: e1002855
34. Friday BB, Adjei AA. K-ras as a target for cancer therapy. Biochim Biophys Acta 2005, 1756: 127-144
35. Arvanitakis M, Van Laethem JL, Parma J, De Maertelaer V, Delhaye M, Deviere J. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Endoscopy 2004, 36: 535-542